• Alcon Research, LLC v. Aurion Biotech, Inc.

    Publication Date: 2025-02-11
    Practice Area: Securities Litigation
    Industry: Investments and Investment Advisory | Pharmaceuticals
    Court: Court of Chancery
    Judge: Chancellor McCormick
    Attorneys: For plaintiff: Jon E. Abramczyk, D. McKinley Measley, Elizabeth A. Mullin Stoffer, Jacob M. Perrone, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE; Monica K. Loseman, John D.W. Partridge, John Turquet Bravard, Gibson, Dunn & Crutcher LLP, Denver, CO; Mary Beth Maloney, Jonathan D. Fortney, Mark H. Mixon, Jr., Gibson, Dunn, Crutcher, New York, NY for plaintiff.
    for defendant: Richard R. Rollo, Travis S. Hunter, John M. O’Toole, Kevin M. Kidwell, Edmond S. Kim, Richards, Layton & Finger, P.A., Wilmington, DE; Brad D. Sorrels, Jessica A. Hartwell, Joshua A. Manning, Wilson Sonsini Goodrich & Rosati P.C., Wilmington, DE for defendant.

    Case Number: 2024-1102-KSJM

    Company did not require preferred stockholder's approval for reverse stock split as the split did not affect the number of authorized shares or fall within the scope of other corporate actions requiring approval under the terms of the stockholder's class of shares.

  • Pacira Biosciences, Inc. v. Fortis Advisors LLC

    Publication Date: 2025-02-04
    Practice Area: Mergers and Acquisitions
    Industry: Health Care | Investments and Investment Advisory | Pharmaceuticals
    Court: Court of Chancery
    Judge: Vice Chancellor Fioravanti
    Attorneys: For plaintiff: Lisa A. Schmidt, Raymond J. DiCamillo, Kevin M. Kidwell, Richards, Layton & Finger, P.A., Wilmington, DE; Anne Champion, Zainab Ahmad, Timothy Sun, Maya Danaher, Gibson, Dunn & Crutcher LLC, New York, NY for plaintiffs.
    for defendant: Lauren K. Neal, Courtney Kurz, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE; Christopher J. Marino, Taylor P. Lovejoy, Davis Malm & D’Agostine, P.C., Boston, MA for defendant.

    Case Number: 2020-0694-PAF

    Court granted declaratory judgment for plaintiffs where extrinsic evidence demonstrated that the parties intended to use national reimbursement rates and for alternative CPT codes to only apply when used and effective for acquired company's product.

  • January 27, 2025 | The Legal Intelligencer

    Ozempic Defendants Seek to Shave 'Tacked On' Claims From MDL Complaint

    Novo Nordisk and Eli Lilly's motion to dismiss took aim at most of the counts asserted in the plaintiffs’ master long-form complaint, however the defendants are saving their challenge to certain claims for later.

    1 minute read

  • January 27, 2025 | The American Lawyer

    The New Global M&A Kings All Have Something in Common

    Kirkland, Latham, Paul Weiss and others have replaced the likes of Sullivan & Cromwell, Clifford Chance and Slaughter and May as the global leaders in M&A over the last 20 years, writes the Global Lawyer.

    1 minute read

  • January 21, 2025 | The American Lawyer

    Private Equity in the UK: The 2025 View From Top Partners

    Senior figures at firms including Latham & Watkins, Clifford Chance, and Sidley Austin, explain what to expect in the coming year in law's most lucrative marketplace.

    1 minute read

  • January 17, 2025 | The American Lawyer

    Skadden Boosts London Ranks With Baker McKenzie Hire

    The news comes just days after it emerged private equity heavyweight Bruce Embley was decamping for Clifford Chance.

    1 minute read

  • January 15, 2025 | The American Lawyer

    Goodwin Hires Quinn Emanuel Partner to Launch Office in Brussels

    Quinn Emanuel also lost its Brussels managing partner to an antitrust boutique and appointed a new office managing partner in the city.

    1 minute read

  • January 13, 2025 | Law.com

    Goodwin to Launch Brussels Office With Quinn Emanuel Antitrust Partner

    Quinn Emanuel also lost its Brussels managing partner to an antitrust boutique and appointed a new office managing partner in the city.

    1 minute read

  • U.S. ex rel. Camburn v. Novartis Pharm. Corp.

    Publication Date: 2025-01-08
    Practice Area: Civil Procedure
    Industry: Federal Government | Pharmaceuticals
    Court: U.S. Court of Appeals for the Second Circuit
    Judge: Circuit Judge Myrna Perez
    Attorneys: For plaintiff: For Plaintiffs-Appellants: Laurie Rubinow, Anna K. D'Agostino, Miller Shah LLP, New York, NY; Bruce D. Parke, Eric L. Young, John C. Roberts, Miller Shah LLP, Philadelphia, PA; Nathan Zipperian, Miller Shah LLP, Fort Lauderdale, FL; Steven A. Schwartz, Timothy N. Mathews, Chimicles Schwartz Kriner & Donaldson-Smith LLP, Haverford, PA, on the briefs, James E. Miller, Miller Shah LLP, Chester, CT.
    for defendant: For Defendant-Appellee: Evan R. Chesler, Damaris Hernández, Benjamin Gruenstein, Cravath, Swaine & Moore LLP, New York, NY.

    Case Number: 22-2708

    Anti-Kickback Statute Claims Only Partly Stated in Qui Tam Suit Against Drug Maker

  • K.O. v. M.O.

    Publication Date: 2025-01-08
    Practice Area: Family Law
    Industry:
    Court: Supreme Court, Kings
    Judge: Justice Jeffrey S. Sunshine
    Attorneys: For plaintiff: Attorney for Plaintiff by: Anne Peyton Bryant, Esq., Bryant & Bleier, LLP, New York, New York.
    for defendant: Attorney for Defendant: Ruth Yang, Esq., New York, New York. Attorney for the Children: Cheryl Charles-Duval, Esq., Brooklyn, New York.

    Case Number: (redacted)

    Court Allows Mother to Relocate Residence Within Brooklyn